JPRN-UMIN000001593已完成4 期
Therapeutic effects of L/N type calcium channel blocker cilnidipine and L type calcium channel blockers on hypertensive patients with chronic kidney disease - Therapeutic effects of L/N type calcium channel blocker cilnidipine and L type calcium channel blockers on hypertensive patients with chronic kidney disease
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine0 个研究点目标入组 60 人开始时间: 2008年12月22日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients already treated with cilnidipine, 2. History of hypersensitivity to cilnidipine, 3. Severe hypertension (clinic BP more than 180/100 mmHg), 4. Severe liver disorder, or severe biliary atresia, 5. Pregnant women, or women suspected of being pregnant.
研究者
相似试验
招募中
不适用
The effect of L/N type Calcium channel blocker on blood pressure variability in elderly hypertensive patientsHypertensionJPRN-UMIN000014843Osaka university graduate school of medicine The department of geriatric medicine and nephrology40
已完成
不适用
The comparison of the effect of calcium channel blockers on blood pressure lowering and presevation of renal function in refractory hypertensive patientsrefractory hypertensionJPRN-UMIN000004909St. Marianna University School of Medicine30
招募中
不适用
Effects of L / N type Ca channel blocker cilnicipine on heart rate and QT time during hemodialysisendstage chronic kidney diseaseJPRN-UMIN000023201Department of Nephrology and Dialysis, Moriguchi Keijinnkai Hospital20
招募中
不适用
Effects of combination drugs of calcium channel blockers and angiotensin II receptor blockers on blood pressure, lipid profile, and glucose metabolism in hypertensive patients with glucose intolerance.HypertensionJPRN-UMIN000006651Juntendo University School of Medicine, Department of Cardiovascular Medicine40
招募中
不适用
Evaluation of L/N type Ca2+ channel blocker (cilnidipine) in hypertension complicated diabetes or sleep apnea syndrome ; Trial for the effects of improvementof arteriosclerosis and renal function.Diabetes/Hypertension/Sleep apnea syndromeJPRN-UMIN000014635Kanazawa Medical Clinic50